Separately, ValuEngine raised shares of Cyanotech Corporation from a sell rating to a hold rating in a report on Monday, August 14th.
Cyanotech Corporation (NASDAQ CYAN) remained flat at $4.55 during midday trading on Monday. The company’s stock had a trading volume of 7,153 shares. The stock’s market cap is $25.87 million. Cyanotech Corporation has a 12 month low of $3.25 and a 12 month high of $5.35. The company’s 50 day moving average is $4.42 and its 200 day moving average is $3.88.
Cyanotech Corporation (NASDAQ:CYAN) last posted its quarterly earnings data on Thursday, August 10th. The biotechnology company reported $0.09 earnings per share (EPS) for the quarter. The business had revenue of $8.81 million during the quarter. Cyanotech Corporation had a negative net margin of 0.07% and a negative return on equity of 0.14%. On average, analysts forecast that Cyanotech Corporation will post ($0.01) earnings per share for the current fiscal year.
ILLEGAL ACTIVITY WARNING: This story was first published by BBNS and is the property of of BBNS. If you are accessing this story on another website, it was copied illegally and republished in violation of US & international copyright laws. The original version of this story can be read at https://baseballnewssource.com/markets/cyanotech-corporation-cyan-upgraded-to-c-by-thestreet/1566294.html.
About Cyanotech Corporation
Cyanotech Corporation is engaged in the production of natural products derived from microalgae for the nutritional supplements market. The Company’s products include Hawaiian Spirulina Pacifica and Hawaiian BioAstin. Hawaiian Spirulina Pacifica is a dietary supplement used for extra energy, a strengthened immune system, cardiovascular benefits and as a source of antioxidant carotenoids.
Receive News & Ratings for Cyanotech Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cyanotech Corporation and related companies with our FREE daily email newsletter.